Parametric Portfolio Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $169M | Buy |
3,282,682
+285,439
| +10% | +$14.7M | 0.09% | 220 |
|
|
2021
Q4 | $150M | Buy |
2,997,243
+67,149
| +2% | +$3.32M | 0.08% | 245 |
|
|
2021
Q3 | $141M | Sell |
2,930,094
-82,989
| -3% | -$4.22M | 0.08% | 240 |
|
|
2021
Q2 | $159M | Buy |
3,013,083
+222,158
| +8% | +$11.6M | 0.09% | 213 |
|
|
2021
Q1 | $138M | Buy |
2,790,925
+241,264
| +9% | +$11.6M | 0.08% | 233 |
|
|
2020
Q4 | $124M | Buy |
2,549,661
+462,288
| +22% | +$22.8M | 0.08% | 229 |
|
|
2020
Q3 | $105M | Sell |
2,087,373
-113,777
| -5% | -$5.86M | 0.08% | 233 |
|
|
2020
Q2 | $112M | Sell |
2,201,150
-215,099
| -9% | -$10.5M | 0.09% | 202 |
|
|
2020
Q1 | $106M | Buy |
2,416,249
+186,955
| +8% | +$8.95M | 0.1% | 186 |
|
|
2019
Q4 | $112M | Buy |
2,229,294
+125,882
| +6% | +$5.9M | 0.08% | 227 |
|
|
2019
Q3 | $97.5M | Buy |
2,103,412
+59,672
| +3% | +$2.57M | 0.08% | 242 |
|
|
2019
Q2 | $88.4M | Sell |
2,043,740
-3,266
| -0.2% | -$139K | 0.07% | 255 |
|
|
2019
Q1 | $90.6M | Sell |
2,047,006
-2,619
| -0.1% | -$112K | 0.08% | 241 |
|
|
2018
Q4 | $89M | Buy |
2,049,625
+179,258
| +10% | +$7.91M | 0.09% | 218 |
|
|
2018
Q3 | $83.5M | Buy |
1,870,367
+170,217
| +10% | +$7.27M | 0.07% | 256 |
|
|
2018
Q2 | $68M | Buy |
1,700,150
+101,143
| +6% | +$3.98M | 0.06% | 292 |
|
|
2018
Q1 | $64.1M | Buy |
1,599,007
+48,640
| +3% | +$2.02M | 0.06% | 293 |
|
|
2017
Q4 | $66.7M | Sell |
1,550,367
-8,033
| -0.5% | -$370K | 0.07% | 283 |
|
|
2017
Q3 | $77.6M | Buy |
1,558,400
+101,718
| +7% | +$4.92M | 0.08% | 236 |
|
|
2017
Q2 | $69.8M | Sell |
1,456,682
-3,598
| -0.2% | -$172K | 0.08% | 231 |
|
|
2017
Q1 | $66.1M | Buy |
1,460,280
+295,242
| +25% | +$12.5M | 0.1% | 169 |
|
|
2016
Q4 | $47.1M | Buy |
1,165,038
+123,276
| +12% | +$4.86M | 0.07% | 296 |
|
|
2016
Q3 | $39.8M | Sell |
1,041,762
-69,217
| -6% | -$2.78M | 0.06% | 328 |
|
|
2016
Q2 | $46.5M | Buy |
1,110,979
+56,146
| +5% | +$2.3M | 0.07% | 275 |
|
|
2016
Q1 | $42.4M | Buy |
1,054,833
+56,211
| +6% | +$2.26M | 0.07% | 284 |
|
|
2015
Q4 | $42.6M | Sell |
998,622
-126,510
| -11% | -$5.82M | 0.07% | 270 |
|
|
2015
Q3 | $53.4M | Buy |
1,125,132
+93,870
| +9% | +$4.78M | 0.1% | 202 |
|
|
2015
Q2 | $51.1M | Buy |
1,031,262
+60,304
| +6% | +$3.06M | 0.1% | 207 |
|
|
2015
Q1 | $48M | Buy |
970,958
+108,459
| +13% | +$5.19M | 0.1% | 215 |
|
|
2014
Q4 | $39.3M | Sell |
862,499
-107,730
| -11% | -$5.23M | 0.08% | 252 |
|
|
2014
Q3 | $54.8M | Sell |
970,229
-47,978
| -5% | -$2.58M | 0.12% | 172 |
|
|
2014
Q2 | $54.1M | Buy |
1,018,207
+47,942
| +5% | +$2.54M | 0.12% | 175 |
|
|
2014
Q1 | $50.7M | Buy |
970,265
+64,109
| +7% | +$3.25M | 0.12% | 176 |
|
|
2013
Q4 | $48.6M | Buy |
906,156
+10,255
| +1% | +$529K | 0.12% | 178 |
|
|
2013
Q3 | $45.4M | Buy |
895,901
+25,406
| +3% | +$1.29M | 0.12% | 166 |
|
|
2013
Q2 | $44.8M | Buy |
+870,495
| New | +$46.4M | 0.13% | 152 |
|
Other funds holding SNY
CCM
Parametric Portfolio Associates's SNY Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Sanofi (SNY) stake by 9.5% in Q1 2022, buying an estimated $14.7M and bringing the position to 3,282,682 shares worth $169M. The position accounts for 0.09% of the portfolio, ranked #220.
Parametric Portfolio Associates first reported a position in SNY in Q2 2013 and has held it in 36 quarters since. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.
- Parametric Portfolio Associates held 3,282,682 shares of Sanofi worth $169M as of Q1 2022.
- Parametric Portfolio Associates bought 285,439 Sanofi shares in Q1 2022, an estimated $14.7M.
- Sanofi made up 0.09% of Parametric Portfolio Associates's portfolio in Q1 2022, its #220 holding.
- Parametric Portfolio Associates first reported a position in Sanofi in Q2 2013 and has held it in 36 quarters since.
- 623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.